Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.

Abstract:

BACKGROUND:Chronic kidney disease (CKD) can be associated with a higher risk of progression to end-stage renal disease and mortality, but the etiology of nephron loss may modify this. Previous studies suggested that CKD primarily due to surgical removal of nephrons (CKD-S) may be more stable and associated with better survival than CKD due to medical causes (CKD-M). OBJECTIVE:We addressed limitations of our previous work with comprehensive control for confounding factors, differentiation of non-renal cancer-related mortality, and longer follow-up for more discriminatory assessment of the impact of CKD-S. DESIGN, SETTING, AND PARTICIPANTS:From 1999 to 2008, 4299 patients underwent surgery for renal cancer at a single institution. The median follow-up was 9.4 yr (7.3-11.0). The new baseline glomerular filtration rate (GFR) was defined as the highest GFR between the nadir and 42 d after surgery. Three cohorts were retrospectively evaluated: no CKD (new baseline GFR >60 ml/min/1.73 m(2)); CKD-S (new baseline GFR<60 but preoperative >60 ml/min/1.73 m(2)); and CKD-M/S (new baseline and preoperative GFR both <60 ml/min/1.73 m(2)). Cohort status was permanently set at 42 d after surgery. INTERVENTION:Renal surgery. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:Decline in renal function (50% reduction in GFR or dialysis), all-cause mortality, and non-renal cancer mortality were examined using a multivariable Cox proportional hazards model. RESULTS AND LIMITATIONS:CKD-M/S had a higher incidence of relevant comorbidities and the new baseline GFR was lower. On multivariable analysis (controlling for age, gender, race, diabetes, hypertension, and cardiac disease), CKD-M/S had higher rates of progressive decline in renal function, all-cause mortality, and non-renal cancer mortality when compared to CKD-S and no CKD (hazard ratio [HR] 1.69-2.33, all p<0.05). All-cause mortality was modestly higher for CKD-S than for no CKD (HR 1.19, p=0.030), but renal stability and non-renal cancer mortality were similar for these groups. New baseline GFR of <45 ml/min/1.73 m(2) significantly predicted adverse outcomes. The main limitation is the retrospective design. CONCLUSIONS:CKD-S is more stable than CKD-M/S and has better survival, approximating that for no CKD. However, if the new baseline GFR is <45 ml/min/1.73 m(2), the risks of functional decline and mortality increase. These findings may influence counseling for patients with localized renal cell carcinoma and higher oncologic potential when a normal contralateral kidney is present. PATIENT SUMMARY:Survival is better for surgically induced chronic kidney disease (CKD) than for medically induced CKD, particularly if the postoperative glomerular filtration rate is ≥45 ml/min/1.73 m(2). Patients with preexisting CKD are at risk of a significant decline in kidney function after surgery, and kidney-preserving treatment should be strongly considered in such cases.

journal_name

Eur Urol

journal_title

European urology

authors

Lane BR,Demirjian S,Derweesh IH,Takagi T,Zhang Z,Velet L,Ercole CE,Fergany AF,Campbell SC

doi

10.1016/j.eururo.2015.04.043

subject

Has Abstract

pub_date

2015-12-01 00:00:00

pages

996-1003

issue

6

eissn

0302-2838

issn

1873-7560

pii

S0302-2838(15)00402-9

journal_volume

68

pub_type

杂志文章
  • Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.

    abstract:BACKGROUND:Neutrophil-to-lymphocyte ratio (NLR), if elevated, is associated with worse outcomes in several malignancies. OBJECTIVE:Investigation of NLR at baseline and during therapy for metastatic renal cell carcinoma. DESIGN, SETTING, AND PARTICIPANTS:Retrospective analysis of 1199 patients from the International M...

    journal_title:European urology

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.eururo.2016.02.033

    authors: Templeton AJ,Knox JJ,Lin X,Simantov R,Xie W,Lawrence N,Broom R,Fay AP,Rini B,Donskov F,Bjarnason GA,Smoragiewicz M,Kollmannsberger C,Kanesvaran R,Alimohamed N,Hermanns T,Wells JC,Amir E,Choueiri TK,Heng DY

    更新日期:2016-08-01 00:00:00

  • The role of the prostatic vasculature as a landmark for nerve sparing during robot-assisted radical prostatectomy.

    abstract:BACKGROUND:Macroscopic landmarks are lacking to identify the cavernosal nerves (CNs) during radical prostatectomy. The prostatic and capsular arteries run along the lateral border of the prostate and could help identify the location of the CNs during robot-assisted radical prostatectomy (RARP). OBJECTIVE:Describe the ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2011.12.047

    authors: Patel VR,Schatloff O,Chauhan S,Sivaraman A,Valero R,Coelho RF,Rocco B,Palmer KJ,Kameh D

    更新日期:2012-03-01 00:00:00

  • Our experience with retroperitoneal and transperitoneal laparoscopic pyeloplasty for pelvi-ureteric junction obstruction.

    abstract:OBJECTIVE:Laparoscopic dismembered pyeloplasty has been quoted to have equivalent success rates to the traditional open procedure in the treatment of pelvi-ureteric junction obstruction (PUJO). The aim of this study was to report our experience with laparoscopic pyeloplasty. PATIENTS AND METHODS:All patients with PUJO...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2005.08.004

    authors: Davenport K,Minervini A,Timoney AG,Keeley FX Jr

    更新日期:2005-12-01 00:00:00

  • EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).

    abstract::A short version of the UTI Guidelines elaborated by the Urinary Tract Infection Working Group of the Health Care Office of the European Association of Urology is presented. The topics include classification, diagnosis, treatment and follow-up of uncomplicated UTI, UTI in children, UTI in diabetes mellitus, renal insuf...

    journal_title:European urology

    pub_type: 指南,杂志文章,实务指引

    doi:10.1159/000049840

    authors: Naber KG,Bergman B,Bishop MC,Bjerklund-Johansen TE,Botto H,Lobel B,Jinenez Cruz F,Selvaggi FP,Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).

    更新日期:2001-11-01 00:00:00

  • Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder cancer patients.

    abstract:OBJECTIVES:The purpose of this study was to evaluate the association between the serum anti-p53 antibodies (Abs) status and the p53 protein status in the sera and tumors as well as clinical or pathological parameters in bladder cancer patients retrospectively. METHODS:Serum samples from 100 patients with bladder cance...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000020104

    authors: Morita T,Tachikawa N,Kumamaru T,Nukui A,Ikeda H,Suzuki K,Tokue A

    更新日期:2000-01-01 00:00:00

  • PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone.

    abstract:OBJECTIVES:To assess the factors effecting PSA bounce and to identify any possible relationship with biochemical control after 3-D conformal radiotherapy (3D-CRT) and total androgen deprivation (TAD) for prostate cancer by evaluating four previously described PSA bounce definitions. METHODS:Between January 1998 and Ja...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2005.04.007

    authors: Akyol F,Ozyigit G,Selek U,Karabulut E

    更新日期:2005-07-01 00:00:00

  • Congenital bladder diverticula in infants.

    abstract:OBJECTIVE:Congenital bladder diverticula (CBD) usually occur in areas where the muscle is inadequately formed, typically at the ureterovesical junction, or between bundles of hypertrophied muscle. CBD are mostly asymptomatic and the cases are found incidentally. Occasionally, some cases of CBD may produce urinary obstr...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000019520

    authors: Sarihan H,Abes M

    更新日期:1998-01-01 00:00:00

  • Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.

    abstract:BACKGROUND:Limited data exist to guide the use of androgen deprivation therapy (ADT) for men treated with radiation therapy (RT) after radical prostatectomy (RP). The optimal duration of ADT in this setting is unknown. OBJECTIVE:To determine if the duration of ADT influences clinical outcomes for men receiving post-RP...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2015.05.009

    authors: Jackson WC,Schipper MJ,Johnson SB,Foster C,Li D,Sandler HM,Palapattu GS,Hamstra DA,Feng FY

    更新日期:2016-01-01 00:00:00

  • Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.

    abstract:OBJECTIVE:To compare OAB symptom outcomes following initial randomised treatment with solifenacin 5 mg or tolterodine ER 4 mg at the 4-week clinic-visit and again at 12 weeks for patients choosing to remain on this treatment dose from 4 weeks. METHODS:A prospective, double blind, double-dummy, two-arm, parallel-group,...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.eururo.2007.05.027

    authors: Chapple CR,Fianu-Jonsson A,Indig M,Khullar V,Rosa J,Scarpa RM,Mistry A,Wright DM,Bolodeoku J,STAR study group.

    更新日期:2007-10-01 00:00:00

  • Prospective evaluation of the functional sling suspension for male postprostatectomy stress urinary incontinence: results after 1 year.

    abstract:BACKGROUND:Although surgical techniques for radical prostatectomy (RP) have been refined significantly, a significant number of patients still suffer from persisting postprostatectomy stress urinary incontinence (SUI). In recent years, various minimally invasive sling systems have been investigated as treatment options...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.eururo.2009.07.028

    authors: Bauer RM,Mayer ME,Gratzke C,Soljanik I,Buchner A,Bastian PJ,Stief CG,Gozzi C

    更新日期:2009-12-01 00:00:00

  • Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent prostate cancer foci.

    abstract:BACKGROUND:Perineural invasion is discussed as a significant route of extraprostatic extension in prostate cancer (PCa). Recent in vitro studies suggested a complex mechanism of neuroepithelial interaction. OBJECTIVE:The present study was intended to investigate whether the concept of neuroepithelial interaction can b...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2013.04.043

    authors: Bründl J,Schneider S,Weber F,Zeman F,Wieland WF,Ganzer R

    更新日期:2014-04-01 00:00:00

  • Preoperative and postoperative evaluation of prostate-specific antigen in localized prostatic cancer treated by radical prostatectomy.

    abstract::Preoperative prostate-specific antigen (PSA) values were determined in 73 patients with clinically localized prostatic cancer and candidates for a radical procedure. Correlation of preoperative PSA with a final pathological stage was attempted. Only in 44.8% of our 22 patients with organ-confined disease was the PSA v...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474902

    authors: Zattoni F,Piazza R,Vianello R,Garbeglio A,Pagano F

    更新日期:1992-01-01 00:00:00

  • Nephrostomy tube or 'JJ' ureteric stent in ureteric obstruction: assessment of patient perspectives using quality-of-life survey and utility analysis.

    abstract:INTRODUCTION:Upper urinary tract obstruction is often relieved by either a percutaneous nephrostomy tube (PCN) or a ureteric stent. Both can cause considerable morbidity and reduce patient's health-related quality of life (QoL). We have compared the QoL in these 2 groups. PATIENTS AND METHODS:34 patients (21 stent and...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000052529

    authors: Joshi HB,Adams S,Obadeyi OO,Rao PN

    更新日期:2001-06-01 00:00:00

  • Innovations in Statistical Review at European Urology.

    abstract::European Urology has established three principles for improving the quality of statistics in papers published in our journal: (1) systematic guidance for authors based on common statistical errors in urology research; (2) all papers with substantive statistics are reviewed by a statistician; and (3) ongoing innovation...

    journal_title:European urology

    pub_type: 社论

    doi:10.1016/j.eururo.2018.09.046

    authors: Assel M,Sjoberg DD,Catto JWF,Vickers AJ

    更新日期:2019-01-01 00:00:00

  • Burch colposuspension and tension-free vaginal tape in the management of stress urinary incontinence in women.

    abstract:OBJECTIVE:Objective of the study was to compare the efficacy and the complications of tension-free vaginal tape (TVT) and Burch colposuspension in the treatment of female genuine stress incontinence (GSI). METHODS:In this controlled, prospective, randomized study, participated 35 patients who underwent Burch colposusp...

    journal_title:European urology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0302-2838(02)00033-7

    authors: Liapis A,Bakas P,Creatsas G

    更新日期:2002-04-01 00:00:00

  • Urinary cytokeratin 20 as a marker for transitional cell carcinoma.

    abstract:OBJECTIVES:To determine if detection of cytokeratin 20 (CK20) gene expression, by reverse transcriptase-polymerase chain reaction (RT-PCR) in urine from transitional cell carcinoma (TCC) patients, can provide a new noninvasive tool for the follow-up of patients with urothelial carcinoma of the bladder. METHODS:Urine w...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000020199

    authors: Rotem D,Cassel A,Lindenfeld N,Mecz Y,Sova Y,Resnick M,Stein A

    更新日期:2000-05-01 00:00:00

  • Testicular-sparing surgery for the prepubertal testicular tumor. Experience of two cases with large cell calcifying Sertoli cell tumors.

    abstract:PURPOSE:We review prepubertal germ cell tumors of testis in our institute and the Japanese registry and present 2 cases with a large cell calcifying Sertoli cell tumor (LCCSCT) and discuss the possibility of testis-sparing surgery. MATERIALS AND METHODS:Incidence, age, pathology and clinical stages of prepubertal germ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000049860

    authors: Nonomura K,Koyama T,Kakizaki H,Murakumo M,Shinohara N,Koyanagi T

    更新日期:2001-12-01 00:00:00

  • Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE).

    abstract:BACKGROUND:Incontinence has a greater detrimental effect on quality of life than other symptoms of overactive bladder (OAB) and is often difficult to treat with antimuscarinic monotherapy. OBJECTIVE:To evaluate the efficacy and the safety and tolerability of combination (solifenacin 5mg and mirabegron 50mg) versus sol...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.eururo.2016.02.030

    authors: Drake MJ,Chapple C,Esen AA,Athanasiou S,Cambronero J,Mitcheson D,Herschorn S,Saleem T,Huang M,Siddiqui E,Stölzel M,Herholdt C,MacDiarmid S,BESIDE study investigators.

    更新日期:2016-07-01 00:00:00

  • EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis.

    abstract:CONTEXT:Low-dose computed tomography (CT) has become the first choice for detection of ureteral calculi. Conservative observational management of renal stones is possible, although the availability of minimally invasive treatment often leads to active treatment. Acute renal colic due to ureteral stone obstruction is an...

    journal_title:European urology

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.eururo.2015.07.040

    authors: Türk C,Petřík A,Sarica K,Seitz C,Skolarikos A,Straub M,Knoll T

    更新日期:2016-03-01 00:00:00

  • Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?

    abstract:BACKGROUND:A new edition of the TNM was recently released that includes modifications for the staging system of kidney cancers. Specifically, T2 cancers were subclassified into T2a and T2b (< or =10 cm vs >10 cm), tumors with renal vein involvement or perinephric fat involvement were classified as T3a cancers, and thos...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.eururo.2010.07.006

    authors: Novara G,Ficarra V,Antonelli A,Artibani W,Bertini R,Carini M,Cosciani Cunico S,Imbimbo C,Longo N,Martignoni G,Martorana G,Minervini A,Mirone V,Montorsi F,Schiavina R,Simeone C,Serni S,Simonato A,Siracusano S,Volpe A

    更新日期:2010-10-01 00:00:00

  • Clinical relevance of growth factor antagonists in the treatment of benign prostatic hyperplasia.

    abstract::Changing demography and expectations about maintaining quality of life mean that an increasing number of men will require treatment for benign prostatic hyperplasia (BPH). Many growth factors have a role in the development of BPH. Consequently growth factor antagonists offer an attractive therapeutic option. In double...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:

    authors: Desgrandchamps F

    更新日期:1997-01-01 00:00:00

  • Efficacy, safety, and tolerability of mirabegron in patients aged ≥65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR).

    abstract:BACKGROUND:The majority of patients with overactive bladder (OAB) are aged >65yr. There has been no prospectively designed study assessing treatment efficacy with the β3-adrenoreceptor agonist, mirabegron, specifically in this age group. OBJECTIVE:A phase IV study comparing flexibly dosed mirabegron versus placebo in ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2019.10.002

    authors: Wagg A,Staskin D,Engel E,Herschorn S,Kristy RM,Schermer CR

    更新日期:2020-02-01 00:00:00

  • Identification of new prostate cancer progression markers by differential hybridization analysis.

    abstract::In studies on the onset and progression of cancer, molecular biology has proven to be very useful. Reasoning that tumorigenesis can be considered as a multistep process in which a normal cell gradually escapes from its delicately regulated growth pattern, one might describe this process in terms of gene expression. Th...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000474893

    authors: Schalken JA,Debruyne FM

    更新日期:1992-01-01 00:00:00

  • Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: a phase-II study.

    abstract:OBJECTIVES:Amsacrine, as a single agent, was reported to be effective in patients with metastatic transitional cell carcinoma of the urinary bladder. Amsacrine is also associated with a lower toxicity than cyclophosphamide, doxorubicin and cisplatin therapy and has similar activity. But amsacrine has been forgotten in ...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000049794

    authors: Popov I,Jelíc S,Radosavljevíc D,Nikolíc-Tomasevíc Z

    更新日期:2001-09-01 00:00:00

  • Cyproterone acetate lead-in prevents initial rise of serum testosterone induced by luteinizing hormone-releasing hormone analogs in the treatment of metastatic carcinoma of the prostate.

    abstract::Luteinizing hormone-releasing hormone (LH-RH) analogs are an effective treatment of metastatic carcinoma of the prostate. However, they induce an initial rise in serum testosterone responsible for 10-30% of diseases flares. The efficacy of the antiandrogen cyproterone acetate (CPA) was tested in 15 patients with metas...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000472667

    authors: Boccon-Gibod L,Laudat MH,Dugue MA,Steg A

    更新日期:1986-01-01 00:00:00

  • A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.

    abstract:BACKGROUND:Many men (21-52%) are reported to have no cancer on the second, also known as the confirmatory, biopsy (B2) for prostate cancer active surveillance (AS). If these men had a reduced risk of pathologic progression, particularly grade related, the intensity of their follow-up could be decreased. OBJECTIVE:To i...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2013.04.038

    authors: Wong LM,Alibhai SM,Trottier G,Timilshina N,Van der Kwast T,Zlotta A,Lawrentschuk N,Kulkarni G,Hamilton R,Ferrara S,Margel D,Trachtenberg J,Jewett MA,Toi A,Evans A,Fleshner NE,Finelli A

    更新日期:2014-09-01 00:00:00

  • Effects of 3 months' neoadjuvant hormonal treatment with a GnRH analogue (triptorelin) prior to radical retropubic prostatectomy on prostate-specific antigen and tumour volume in prostate cancer.

    abstract::In this retrospective study the relationship between serum prostate-specific antigen (PSA) and tumour volume (assessed by the planimetric method on whole mount section) was analysed in 56 patients subjected to radical prostatectomy, of whom 28 received 3 months of neoadjuvant GnRH analogue (triptorelin) treatment. Ser...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000475337

    authors: Aus G,Brändstedt S,Häggman M,Pedersen K,de la Torre M,Hugosson J

    更新日期:1994-01-01 00:00:00

  • Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation.

    abstract:INTRODUCTION:Robotic-assisted laparoscopic radical prostatectomy (RLRP) is increasingly becoming an alternative to open and laparoscopic radical prostatectomy in the treatment of localized prostate cancer. RLRP has been associated with low morbidity, short convalescence and comparable oncologic and functional outcomes....

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2006.10.019

    authors: Zorn KC,Gofrit ON,Orvieto MA,Mikhail AA,Zagaja GP,Shalhav AL

    更新日期:2007-03-01 00:00:00

  • Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: results of a prospective multicenter study.

    abstract:PURPOSE:This prospective, multicenter study was initiated to evaluate the diagnostic performance of PSA, free/total PSA (f/tPSA) and complexed PSA (cPSA) with volume-based parameters for early detection of prostate cancer in patients with PSA between 2.5 and 20 ng/ml. MATERIALS AND METHODS:408 subjects with serum PSA ...

    journal_title:European urology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.eururo.2004.10.009

    authors: Sözen S,Eskicorapci S,Küpeli B,Irkilata L,Altinel M,Ozer G,Uygur C,Alkibay T,Ozen H

    更新日期:2005-03-01 00:00:00

  • Recoverability of erectile function in post-radical cystectomy patients: subjective and objective evaluations.

    abstract:BACKGROUND:Literature regarding both subjective and objective evaluations of erectile function following radical cystectomy is deficient. OBJECTIVE:To study the recoverability of erectile function in post-radical cystectomy patients on subjective and objective bases. DESIGN, SETTING, AND PARTICIPANTS:Between March 20...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2008.06.072

    authors: Hekal IA,El-Bahnasawy MS,Mosbah A,El-Assmy A,Shaaban A

    更新日期:2009-02-01 00:00:00